glp-1 news updates november 2025 ISPOR 2025: Exploring reasons for discontinuation GLP-1 Trends

The Senate voted for the measure Wednesday

This study underscores key sociodemographic disparities in GLP-1RA prescribing among breast cancer patients with T2DM, highlighting inequities that persist even among populations at heightened risk for adverse health sequelae, such as those with overweight/obesity

states, so you can get OMG

Dose at 0.2g per kilogram of bodyweight your first time, work up to 0.3g per kg, and take it 90 to 120 minutes before your effort

Understanding these genetic factors can support a more informed conversation with your provider about whether GLP-1 useduring or after breastfeedingaligns with your metabolic profile and timeline

Fits through your letterbox